RSAD Antibodies

Santa Cruz Biotechnology features a diverse variety of RSAD Antibodies for studying RSAD, a protein known for its role in the innate immune response and antiviral defense mechanisms. Monoclonal RSAD Antibodies are compatible with multiple research techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). RSAD is involved in the regulation of cellular responses to viral infections and plays a significant role in the production of interferons, which are essential for the antiviral state of cells. Understanding RSAD function is crucial for developing therapeutic strategies against viral diseases and enhancing our knowledge of immune system dynamics. RSAD participates in multiple cellular pathways that influence immune response and viral defense. Researchers have identified several key interactions between RSAD and other immune system components, highlighting its importance in maintaining cellular health. Current investigations focus on understanding how RSAD influences various immune responses and its potential therapeutic applications. RSAD research using Santa Cruz Biotechnology monoclonal antibodies continues to advance our understanding of immune system regulation and viral defense mechanisms, supporting breakthrough discoveries in immunology and virology.